Aggressive cancer cells halted

June 10, 2016, Leiden University

Zebrafish-human communication shows that cancer cells lacking a signaling protein are less able to develop aggressive metastatic properties. This discovery has been made by Claudia Tulotta. PhD defence 14 June.

Cancer cells create favourable circumstances for themselves in the human body. They do this by manipulating the body's direct environment, like immune cells, so that they do not attack but rather assist cancer cells. Scientists want to know how this interaction between cancer and immune calls works. This knowledge may provide possible starting points for halting the development of cancer.

Tulotta studied this interaction not in the , but in zebrafish embryos. Zebrafish has been increasingly used as a model to study cancer biology and similarities between zebrafish and human immune system are present. Tulotta injected fluorescent human cancer cells into the blood circulation of transparent two-day-old zebrafish embryos, with fluorescent blood vessels and . This made it possible for her to track the development and spread of the cancer cells in the living organism, while simultaneously interacting with surrounding zebrafish cells.

She studied two specific proteins. One – CXCR4 – is a product of cancer cells that is found on the surface of the cell. It plays an important role in the movement of cancer cells in response to another , CXCL12. This second protein can be found in both zebrafish and humans. It is produced by organs where tumor metastases are formed.

Tulotta: 'I have shown that cancer cells that produce a lot of CXCR4 behave more aggressively than cells with less CXCR4, in the . Aggressive cells leave the bloodstream and penetrate local tissues, where they can multiply. You can see this as an early step in the formation of metastases.

Tulotta applied two different methods to block the function of CXCR4. First, a pharmacological method: using a recently discovered inhibitor that prevents the protein from doing its work. The second method was genetic: CXCR4 gene function was impaired resulting in no protein production. Using both approaches, the aggressive behavior of cancer cells was halted.

Tulotta also carried out tests on zebrafish embryos that do not produce the CXCL12 protein. The introduced as part of the experiment did not demonstrate aggressive behaviour in these fish. 'This finding suggests that human and zebrafish cells communicate with each other, making the zebrafish embryo model suitable to study tumor behavior and interaction with the surrounding microenvironment.'

Tulotta believes there are opportunities for testing new CXCR4 inhibitors as a possible cancer treatment. The research may also be applied to drug development for other forms of cancer. Inhibiting CXCR4 was also shown to prevent metastasis initiation of Ewing sarcoma, a very rare form of bone cancer, in zebrafish.

Explore further: Signalling protein plays different roles in breast cancer and normal cells

Related Stories

Signalling protein plays different roles in breast cancer and normal cells

June 20, 2014
A key step in developing effective cancer therapies is identifying differences between normal, healthy cells and cancer cells – these differences can then be exploited to specifically kill tumour cells.

Researcher discovers a protein that spreads cancer

April 13, 2016
Nils Halberg at the University of Bergen has identified a protein that makes it possible for cancer cells to spread.

Fighting cancer with the help of someone else's immune cells

May 19, 2016
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone ...

Zebrafish help decode link between calcium deficiency and colon cancer

December 13, 2013
A tiny, transparent fish embryo and a string of surprises led scientists to a deeper understanding of the perplexing link between low calcium and colon cancer.

What can we learn from zebrafish about human blood disorders?

May 6, 2016
Genetic regulation of the various types of blood cells in zebrafish and humans is highly similar, making it relatively easy and cost-effective to perform genetic, chemical, imaging and other molecular studies on this invaluable ...

Disrupting tumor cell 'microenvironment' suggests a new way to treat a prevalent childhood leukemia

June 8, 2015
Researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center are reporting a potentially important discovery in the battle against one of the most devastating forms of leukemia that accounts ...

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.